|
GB1591490A
(en)
*
|
1977-08-04 |
1981-06-24 |
Abbott Lab |
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
|
|
US4188390A
(en)
*
|
1977-11-05 |
1980-02-12 |
Pfizer Inc. |
Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
|
|
FR2421888A1
(fr)
*
|
1978-02-06 |
1979-11-02 |
Synthelabo |
Amides d'alkylene-diamines et leur application en therapeutique
|
|
US4197301A
(en)
*
|
1978-10-16 |
1980-04-08 |
Allergan Pharmaceuticals, Inc. |
Topical ophthalmic use of Prazosin
|
|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
DK121080A
(da)
*
|
1979-04-25 |
1980-10-26 |
Pfizer |
Fremgangsmaade til fremstilling af 2-piperazinoquinazolinderivater
|
|
EP0022481A1
(en)
*
|
1979-06-21 |
1981-01-21 |
Mitsubishi Yuka Pharmaceutical Co., Ltd. |
5,6-Alkylenepyrimidine derivatives, processes for preparing the same and pharmaceutical compositions
|
|
HU180708B
(en)
*
|
1979-10-11 |
1983-04-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing new 1,2,4-oxadiazine derivatives
|
|
US4351940A
(en)
*
|
1980-03-03 |
1982-09-28 |
Pfizer Inc. |
Chloro- and alkoxy-substituted-2-chloro-4-aminodquinazolines
|
|
US4367335A
(en)
*
|
1981-08-03 |
1983-01-04 |
Mead Johnson & Company |
Thiazolidinylalkylene piperazine derivatives
|
|
DE3346675A1
(de)
*
|
1983-12-23 |
1985-07-04 |
Beiersdorf Ag, 2000 Hamburg |
Substituierte 1-(4-amino-6,7-dialkoxy-chinazolinyl)-4- cyclohexenyl-derivate des piperazins und homopiperazins, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen und zwischenprodukte
|
|
FI79107C
(fi)
*
|
1984-06-25 |
1989-11-10 |
Orion Yhtymae Oy |
Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
|
|
CA1307786C
(en)
*
|
1984-12-14 |
1992-09-22 |
Keiichi Yokoyama |
Quinazoline derivatives and antihypertensive preparations containing same as effective components
|
|
DE3683760D1
(de)
*
|
1986-03-21 |
1992-03-12 |
Heumann Pharma Gmbh & Co |
Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
|
|
YU70890A
(en)
*
|
1989-04-21 |
1992-05-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for obtaining quinazoline derivatives
|
|
JPH03286800A
(ja)
*
|
1990-04-03 |
1991-12-17 |
Gunze Ltd |
衣類の折畳み装置
|
|
US5212176A
(en)
*
|
1990-06-29 |
1993-05-18 |
Abbott Laboratories |
R(+)-terazosin
|
|
IL101243A
(en)
*
|
1991-03-20 |
1999-12-22 |
Merck & Co Inc |
Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history
|
|
CA2077252C
(en)
*
|
1992-08-31 |
2001-04-10 |
Khashayar Karimian |
Methods of making ureas and guanidines, and intermediates therefor
|
|
US5294615A
(en)
*
|
1993-04-29 |
1994-03-15 |
Abbott Laboratories |
Terazosin polymorph and pharmaceutical composition
|
|
US5412095A
(en)
*
|
1993-04-29 |
1995-05-02 |
Abbott Laboratories |
Terazosin monohydrochloride and processes and intermediate for its production
|
|
IT1270993B
(it)
*
|
1994-03-18 |
1997-05-26 |
Recordati Chem Pharm |
Derivati chinzolilamminici attivi come alfa-antagonisti
|
|
US5504207A
(en)
*
|
1994-10-18 |
1996-04-02 |
Abbott Laboratories |
Process and intermediate for the preparation of terazosin hydrochloride dihydrate
|
|
CA2232138A1
(en)
*
|
1995-09-29 |
1997-04-03 |
William C. Lumma |
Alpha 1b adrenergic receptor antagonists
|
|
US5587377A
(en)
*
|
1995-10-24 |
1996-12-24 |
Invamed, Inc. |
Terazosin crystalline polymorph and pharmaceutical compositions thereof
|
|
DE19546573A1
(de)
*
|
1995-12-13 |
1997-06-19 |
Uetikon Chemie Gmbh |
Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
|
|
US6177430B1
(en)
|
1997-03-27 |
2001-01-23 |
Pfizer Inc |
Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
|
|
CA2173408C
(en)
*
|
1996-04-03 |
2001-09-04 |
K.S. Keshava Murthy |
Process for the manufacture of intermediates suitable to make doxazosin,terazosin, prazosin, tiodazosin and related antihypertensive medicines
|
|
US5952003A
(en)
*
|
1996-08-01 |
1999-09-14 |
Novartis Corporation |
Terazosin capsules
|
|
IT1286789B1
(it)
*
|
1996-11-29 |
1998-07-17 |
Alfa Chem Ital |
Processo per la produzione della forma i del terazosin monocloridato anidro
|
|
IT1286790B1
(it)
*
|
1996-11-29 |
1998-07-17 |
Alfa Chem Ital |
Processo per la produzione della forma i del terazosin monocloridrato anidro
|
|
GB9700504D0
(en)
*
|
1997-01-11 |
1997-02-26 |
Pfizer Ltd |
Pharmaceutical compounds
|
|
US6248888B1
(en)
|
1997-11-14 |
2001-06-19 |
Teva Pharmaceutical Industries Ltd. |
Process for the preparation of terazosin hydrochloride dihydrate
|
|
EP1118322A4
(en)
|
1998-09-30 |
2004-10-20 |
Takeda Chemical Industries Ltd |
MEDICINES FOR IMPROVING BUBBLE EMPTYING STRENGTH
|
|
US20020065286A1
(en)
*
|
2000-08-21 |
2002-05-30 |
Davies Michael John |
Treatment of wounds
|
|
US20020091129A1
(en)
*
|
2000-11-20 |
2002-07-11 |
Mitradev Boolell |
Treatment of premature ejaculation
|
|
US20030060513A1
(en)
*
|
2001-09-27 |
2003-03-27 |
Arneric Stephen P. |
Pharmaceutical composition
|
|
GB0130219D0
(en)
*
|
2001-12-18 |
2002-02-06 |
Pfizer Ltd |
Compounds for the treatment of sexual dysfunction
|
|
US20030229001A1
(en)
*
|
2002-01-31 |
2003-12-11 |
Pfizer Inc. |
Treatment of male sexual dysfunction
|
|
EP1490090A4
(en)
|
2002-02-22 |
2006-09-20 |
New River Pharmaceuticals Inc |
SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
|
|
GB0219961D0
(en)
|
2002-08-28 |
2002-10-02 |
Pfizer Ltd |
Oxytocin inhibitors
|
|
US7323462B2
(en)
*
|
2002-12-10 |
2008-01-29 |
Pfizer Inc. |
Morpholine dopamine agonists
|
|
CA2679030A1
(en)
|
2002-12-13 |
2004-07-01 |
Warner-Lambert Company Llc |
Alpha-2-delta ligand to treat lower urinary track symptoms
|
|
CA2451267A1
(en)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
PA8597401A1
(es)
*
|
2003-03-14 |
2005-05-24 |
Pfizer |
Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
|
|
US20040220186A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
US20050065158A1
(en)
*
|
2003-07-16 |
2005-03-24 |
Pfizer Inc. |
Treatment of sexual dysfunction
|
|
KR20060126448A
(ko)
|
2003-09-12 |
2006-12-07 |
알러간, 인코포레이티드 |
통증 및 다른 알파 2 아드레날린 매개 증상을 치료하기위한 방법 및 조성물
|
|
US20050059744A1
(en)
*
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
US20050058696A1
(en)
*
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
US7291640B2
(en)
*
|
2003-09-22 |
2007-11-06 |
Pfizer Inc. |
Substituted triazole derivatives as oxytocin antagonists
|
|
US20050267096A1
(en)
*
|
2004-05-26 |
2005-12-01 |
Pfizer Inc |
New indazole and indolone derivatives and their use pharmaceuticals
|
|
US20050288270A1
(en)
*
|
2004-05-27 |
2005-12-29 |
Pfizer Inc |
New aminopyridine derivatives and their use as pharmaceuticals
|
|
CA2500676A1
(en)
*
|
2005-03-11 |
2006-09-11 |
Apotex Pharmachem Inc. |
Preparation of acid addition salts of amine bases by solid phase-gas phase reactions
|
|
DE602006003416D1
(de)
*
|
2005-03-21 |
2008-12-11 |
Pfizer Ltd |
Substituierte triazolderivate als oxytocinantagonisten
|
|
EP1863484A1
(en)
*
|
2005-03-21 |
2007-12-12 |
Pfizer Limited |
Substituted triazole derivatives as oxytocin antagonists
|
|
US20060264442A1
(en)
*
|
2005-05-18 |
2006-11-23 |
Allergan, Inc. |
Methods for the treatment of ocular and neurodegenerative conditions in a mammal
|
|
CA2618103A1
(en)
*
|
2005-08-10 |
2007-02-15 |
Pfizer Limited |
Substituted triazole derivatives as oxytocin antagonists
|
|
US20070086958A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Formation of medically useful gels comprising microporous particles and methods of use
|
|
US20070161791A1
(en)
*
|
2006-01-09 |
2007-07-12 |
Narsimha Reddy Penthala |
Process for the preparation of terazosin hydrocloride dihydrate
|
|
CN101190890B
(zh)
*
|
2006-11-30 |
2011-04-27 |
江苏豪森药业股份有限公司 |
5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺
|
|
US8389531B2
(en)
*
|
2007-07-11 |
2013-03-05 |
Hetero Drugs Limited |
Process for erlotinib hydrochloride
|
|
CN103739596A
(zh)
*
|
2013-12-10 |
2014-04-23 |
刘磊 |
用于心脑血管疾病的喹唑啉衍生物
|
|
US11224572B1
(en)
|
2020-08-17 |
2022-01-18 |
Novitium Pharma LLC |
Stable oral liquid composition of terazosin
|
